Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW
236.00
+1.00 (0.43%)
At close: Apr 8, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | | 812.16M | - | - | - | - | | | |
Pharmaceutical Business Division | | | 62.95B | 64.74B | 55.74B | 50.80B | 49.70B | | | |
Pharmaceutical Business Division Growth | | | -2.76% | 16.14% | 9.74% | 2.20% | 9.49% | | | |
| | | 16.87B | 274.43M | - | - | - | | | |
Bio Business Division Growth | | | 6047.42% | - | - | - | - | | | |
| | | 357.66M | 173.22M | 738.18M | 2.52B | 1.20B | | | |
Game Business Division Growth | | | 106.48% | -76.53% | -70.76% | 110.23% | - | | | |
Insulation Business Division | | | 6.37B | - | - | - | - | | | |
| | | 87.36B | 65.19B | 56.48B | 53.32B | 50.90B | | | |
| | | 34.01% | 15.42% | 5.93% | 4.75% | 12.13% | | | |
Source: S&P Global Market Intelligence.